½ÃÀ庸°í¼­
»óǰÄÚµå
1301207

¼¼°èÀÇ »êºÎÀΰú EHR ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2030³â)

OBGYN EHR Market Size, Share & Trends Analysis Report By Product (Client Server-based, Web-based), By Application (Scheduling, Billing, Clinical Documentation), By Region, And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

»êºÎÀΰú EHR ½ÃÀå ¼ºÀå°ú µ¿Çâ

¼¼°èÀÇ »êºÎÀΰú EHR(OBGYN EHR) ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 33¾ï ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀº 2023³âºÎÅÍ 2030³â»çÀÌ CAGR 9.50%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀå ¼ºÀåÀÇ ¹è°æÀ¸·Î´Â »êºÎÀΰú ÀÇ»çÀÇ ÀüÀÚ ÀÇ·á ±â·Ï(EHR) µµÀÔ Áõ°¡, µ¥ÀÌÅÍ ÅëÇÕÀ»À§ÇÑ EHR ¼ö¿ä Áõ°¡, ½ÅÁ¦Ç° Ãâ½Ã µîÀÌ ÀÖ½À´Ï´Ù. »êºÎÀΰú EHRÀº »êºÎÀΰú ÀÇ»ç ¹× »ê°ú Àǻ簡 ¿öÅ©Ç÷οì, û±¸, ÀüÀÚ Ã³¹æ, ÀÓ»ó ¹®¼­, Áø·á °ü¸®, ¾ÈÀüÇÑ µ¥ÀÌÅÍ Àü¼ÛÀ» °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. 2019³â 7¿ù, WRS Health´Â »ê°ú ÀÇ»ç¿Í »êºÎÀΰú Àǻ簡 ¿öÅ©Ç÷ο츦 ¼öÀÍÀûÀ̰í È¿À²ÀûÀ¸·Î ÃÖÀûÈ­Çϱâ À§ÇÑ ÀüÀÚ Â÷Æ® 'ObGyn-Cloud'ÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù.

ÀÌ´Â ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÕ´Ï´Ù. ¸¹Àº ±¹°¡ÀÇ Á¤ºÎ´Â ´Ù¾çÇÑ Àü¹® ºÐ¾ß¿¡ EHRÀ» µµÀÔÇϱâ À§ÇØ ´Ù¾çÇÑ ³ë·ÂÀ» ´ÙÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡¼­´Â °æÁ¦Àû ¹× ÀÓ»óÀû °Ç°­À» À§ÇÑ ÀÇ·áÁ¤º¸±â¼ú(HITECH)¹ýÀÎ The Health Information Technology for Economic and Clinical Health(HITECH) Act¿¡ µû¶ó EHRÀÇ ÀÇ¹Ì ÀÖ´Â µµÀÔ¿¡ ´ëÇØ ÀçÁ¤Àû Àμ¾Æ¼ºê°¡ Á¦°øµÇ°í ÀÖ½À´Ï´Ù. 2022³â 6¿ù¿¡´Â NHS°¡ ¿µ±¹ÀÇ ¸ðµç Áö¿ª Ŭ¸®´Ð°ú º´¿ø¿¡ ÀüÀÚ ÀÇ·á ±â·ÏÀ» µµÀÔÇÏ´Â µ¥ 24¾ï ´Þ·¯¸¦ ÅõÀÚÇÒ °èȹÀ» ¹ßÇ¥Çß½À´Ï´Ù.

µû¶ó¼­ Á¤ºÎÀÇ °­·ÂÇÑ Áö¿øÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡ °¡Ä¡°üÀ» ±â¹ÝÀ¸·Î ÇÏ´Â Äɾî·ÎÀÇ Àüȯ°ú ÇコÄɾî ÀüüÀÇ ÄÉ¾î »è°¨¿¡ ´ëÇÑ ´ëó°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀº ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. À¯ÇàÀÇ °á°ú·Î °í°´ÀÇ ¼ÒÇÁÆ®¿þ¾î ±¸¸Å ¹× ÇÁ·ÎÁ§Æ®¿Í °°Àº ½Å±Ô ºñÁî´Ï½º ¿¹¾àÀÌ Ãë¼ÒµÇ°Å³ª ¿¬±âµÇ¾î ÁÖ¿ä °ø±Þ¾÷üÀÇ ¼öÀÍ¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. °Ô´Ù°¡ ¸¹Àº º´¿øµéÀÌ È¯ÀÚ ¼öÀÇ °¨¼Ò·Î ÀÎÇÑ ¼öÀÔ °¨¼Ò·Î ÀÎÇØ µðÁöÅÐ ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ °¨¼ÒÇß½À´Ï´Ù.

»êºÎÀΰú EHR ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç°º°·Î À¥ ±â¹Ý EHRÀº 2022³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ´Â ÀÇ»çµé »çÀÌ¿¡¼­ À¥ ±â¹Ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô±â ¶§¹®ÀÔ´Ï´Ù.
  • ¿ëµµº°·Î´Â ¿öÅ©ÇÃ·Î¿ì °ü¸® ºÐ¾ß°¡ 2022³â ½ÃÀåÀÇ ´ëºÎºÐÀ» Â÷ÁöÇß½À´Ï´Ù. ÀüÀÚ ÀÇ·á ±â·ÏÀº »êºÎÀΰú Áø·áÀÇ º¹ÀâÇÑ °úÁ¤À» °£¼ÒÈ­Çϰí ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
  • °ú±Ý ºÐ¾ß´Â RCM ¼Ö·ç¼Ç°ú ÀüÀÚ ÀÇ·á ±â·ÏÀÇ ÅëÇÕÀÌ ÁøÇàµÊ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È À¯¸®ÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì´Â Á¤ºÎÀÇ °­·ÂÇÑ Áö¿ø°ú ÁÖ¿ä °ø±ÞÀÚÀÇ Àü·«Àû Á¸Àç·Î ÀÎÇØ 2022³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀº »êºÎÀΰú Áø·á¼Ò Áõ°¡¿Í °Ç°­ °ü¸® IT ÀÎÇÁ¶óÀÇ ÇöÀúÇÑ ¹ßÀüÀ¸·Î 2023³âºÎÅÍ 2030³â»çÀÌ °¡Àå ±Þ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

  • ½ÃÀå ¼¼ºÐÈ­ ¹× ¹üÀ§
    • ½ÃÀåÀÇ Á¤ÀÇ
  • Áö¿ª ¹üÀ§
  • ÃßÁ¤¡¤¿¹ÃøÀÇ Å¸ÀÓ¶óÀÎ
  • Á¶»ç ¹æ¹ý
  • Á¤º¸ Á¶´Þ
    • ±¸ÀÔÇÑ µ¥ÀÌÅͺ£À̽º
    • GVRÀÇ ³»ºÎ µ¥ÀÌÅͺ£À̽º
    • 2Â÷ Á¤º¸¿Í Á¦3ÀÚÀÇ ½ÃÁ¡
    • 1Â÷ Á¶»ç
  • Á¤º¸ ºÐ¼®
    • µ¥ÀÌÅÍ ºÐ¼® ¸ðµ¨
  • ½ÃÀå Çü¼º°ú µ¥ÀÌÅÍÀÇ ½Ã°¢È­
  • ¸ðµ¨ »ó¼¼
    • »óǰ È帧 ºÐ¼®
  • 2Â÷ Á¤º¸ÀÇ ¸®½ºÆ®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ºÎ¹® ½º³À¼¦
  • °æÀï ±¸µµ ½º³À¼¦

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ ¹× ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼öÀû ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ ºÐ¼®
  • »ç¾÷ ȯ°æ ºÐ¼®
    • PESTLE ºÐ¼®
    • Porter's Five Forces ºÐ¼®
  • COVID-19°¡ °¨¿°ÀÇ ¿µÇ⠺м®

Á¦4Àå Á¦Ç°º° ºñÁî´Ï½º ºÐ¼®

  • »êºÎÀΰú EHR ½ÃÀå : Á¦Ç°º° º¯µ¿ ºÐ¼®(2022³â, 2030³â)
  • Ŭ¶óÀÌ¾ðÆ® ¼­¹ö ±â¹Ý EHR
  • À¥ ±â¹Ý EHR

Á¦5Àå ¿ëµµº° ºñÁî´Ï½º ºÐ¼®

  • »êºÎÀΰú EHR ½ÃÀå : ¿ëµµº° º¯µ¿ ºÐ¼®(2022³â, 2030³â)
  • ¿öÅ©ÇÃ·Î¿ì °ü¸®
  • û±¸
  • ½ºÄÉÁÙ ¼³Á¤
  • ÀÓ»ó ¹®¼­
  • ±âŸ

Á¦6Àå Áö¿ªº° ºñÁî´Ï½º ºÐ¼®

  • Áö¿ª ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ºÏ¹ÌÀÇ »êºÎÀΰú EHR ½ÃÀå(2018-2030³â)
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ÀÇ »êºÎÀΰú EHR ½ÃÀå(2018-2030³â)
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç
    • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ »êºÎÀΰú EHR ½ÃÀå(2018-2030³â)
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ³²¹Ì
    • ³²¹ÌÀÇ »êºÎÀΰú EHR ½ÃÀå(2018-2030³â)
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • MEA
    • MEA »êºÎÀΰú EHR ½ÃÀå(2018-2030³â)
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷ÀÇ ºÐ·ù
  • Àü·« ¸ÅÇÎ
    • Àμö ÇÕº´
    • Äݶ󺸷¹À̼Ç
    • ½ÅÁ¦Ç° ¹ß¸Å
    • ±âŸ
  • ±â¾÷ °³¿ä ¹× ¸ñ·Ï
    • InSync Healthcare Solutions
    • Practice Fusion, Inc.
    • WRS Health.
    • Bizmatics, Inc.
    • Greenway Health, LLC
    • CureMD Healthcare
    • NXGN Management, LLC
    • Infor-Med Inc.
    • EndoSoft LLC
    • RevenueXL Inc.
LYJ 23.07.27

OBGYN EHR Market Growth & Trends

The global OBGYN EHR market size is expected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.50% from 2023 to 2030. The market growth can be attributed to the increasing adoption of electronic health records (EHRs) among gynecologists, increasing demand for EHR for data integration, and new product launches. OBGYN EHR can help gynecologists and obstetricians manage workflow, billing, e-prescribing, clinical documentation, practice management, and secure data transfer. In July 2019, WRS Health announced the launch of ObGyn-Cloud, an electronic health record to help obstetricians and gynecologists optimize their workflow profitably and efficiently.

This is propelling the market growth. The governments of many countries are undertaking various initiatives for the deployment of EHR across various specialties. For instance, under The Health Information Technology for Economic and Clinical Health (HITECH) Act, financial incentives are provided for the meaningful implementation of EHR in the U.S. In June 2022, NHS announced its plans to invest USD 2.4 billion in implementing electronic health records in all community practices and hospitals in the UK.

Thus, strong support from the government is anticipated to drive the market growth. Furthermore, a shift towards value-based care and steps to reduce overall healthcare care are boosting market growth. The COVID-19 pandemic has had a significant impact on the market. As a result of the pandemic, new business bookings, such as client software purchases and projects, were canceled or delayed, which negatively impacted the revenue of key providers. Furthermore, many hospitals suffered revenue losses due to low patient volume, which decreased their investment in digital health technologies.

OBGYN EHR Market Report Highlights

  • Based on the product, the web-based EHR dominated the market in 2022. This can be attributed to the high demand for web-based solutions among physicians
  • In terms of applications, the workflow management segment accounted for a major portion of the market in 2022. Electronic health records streamline the complex process of gynecology practices, thereby fueling the segment growth
  • The billing segment is anticipated to witness lucrative growth during the forecast period owing to the increasing integration of RCM solutions with electronic health records
  • North America dominated the market in 2022 mainly due to strong government support and the strategic presence of key providers
  • Asia Pacific is expected to report the fastest growth from 2023 to 2030 due to the growing number of OB-GYN practices in the region and significant developments in healthcare IT infrastructure

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources & Third-Party Perspectives
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. PESTLE Analysis
    • 3.3.2. Porter's Five Forces Analysis
  • 3.4. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. OBGYN EHR Market: Product Movement Analysis, 2022 & 2030
  • 4.2. Client-server-based EHR
    • 4.2.1. Client-server-based EHR Market, 2018 - 2030 (USD Million)
  • 4.3. Web-based EHR
    • 4.3.1. Global Web-based EHR Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. OBGYN EHR Market: Application Movement Analysis, 2022 & 2030
  • 5.2. Workflow Management
    • 5.2.1. Workflow Management Market, 2018 - 2030 (USD Million)
  • 5.3. Billing
    • 5.3.1. Billing Market, 2018 - 2030 (USD Million)
  • 5.4. Scheduling
    • 5.4.1. Scheduling Market, 2018 - 2030 (USD Million)
  • 5.5. Clinical Documentation
    • 5.5.1. Clinical Documentation Market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America OBGYN EHR Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Competitive Scenario
    • 6.2.3. Canada
      • 6.2.3.1. Canada OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Competitive Scenario
  • 6.3. Europe
    • 6.3.1. Europe OBGYN EHR Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Germany OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Competitive Scenario
    • 6.3.3. UK
      • 6.3.3.1. UK OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Competitive Scenario
    • 6.3.4. France
      • 6.3.4.1. France OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Competitive Scenario
    • 6.3.5. Italy
      • 6.3.5.1. Italy OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Competitive Scenario
    • 6.3.6. Spain
      • 6.3.6.1. Spain OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Competitive Scenario
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Competitive Scenario
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Competitive Scenario
    • 6.3.9. Norway
      • 6.3.9.1. Norway OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Competitive Scenario
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific OBGYN EHR Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Competitive Scenario
    • 6.4.3. China
      • 6.4.3.1. China OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Competitive Scenario
    • 6.4.4. India
      • 6.4.4.1. India OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Competitive Scenario
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Competitive Scenario
    • 6.4.6. Australia
      • 6.4.6.1. Australia OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Competitive Scenario
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Competitive Scenario
  • 6.5. Latin America
    • 6.5.1. Latin America OBGYN EHR Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Competitive Scenario
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Competitive Scenario
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Competitive Scenario
  • 6.6. MEA
    • 6.6.1. MEA OBGYN EHR Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Competitive Scenario
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Competitive Scenario
    • 6.6.4. UAE
      • 6.6.4.1. UAE OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Competitive Scenario
    • 6.6.5. Kuwait
      • 6.6.5.1. UAE OBGYN EHR Market, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Merger & Acquisition
    • 7.2.2. Collaborations
    • 7.2.3. New Product Launches
    • 7.2.4. Others
  • 7.3. Company Profiles/Listing
    • 7.3.1. InSync Healthcare Solutions
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Practice Fusion, Inc.
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. WRS Health.
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Bizmatics, Inc.
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Greenway Health, LLC
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. CureMD Healthcare
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. NXGN Management, LLC
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Infor-Med Inc.
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Product Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. EndoSoft LLC
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Product Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. RevenueXL Inc.
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Product Benchmarking
      • 7.3.10.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦